Latest Sulfonamides Stories
- All six trials met primary efficacy endpoint - PARIS AND TARRYTOWN, N.Y., Nov. 19, 2014 /PRNewswire/ -- Sanofi and Regeneron Pharmaceuticals, Inc.
NASDAQ: CRME TSX: COM VANCOUVER, Nov. 7, 2014 /PRNewswire/ - Cardiome Pharma Corp.
NEW YORK, Oct.
BEERSE, Belgium, September 29, 2014 /PRNewswire/ -- CHMP also issues two label extensions for darunavir Janssen-Cilag International NV (Janssen)
New Treatment Option Combining Protease Inhibitor and Boosting Agent Reduces the Number of Pills Required to Manage HIV TORONTO, Sept. 17, 2014 /CNW/ - Janssen Inc.
Poor diuretic response is associated with worse in-hospital and post-discharge clinical outcomes.
Pulmonary arterial hypertension – a deadly, incurable lung condition – is one of only sixteen disease states FDA will focus on during the first three years of the Patient Focused Drug Development
In patients with idiopathic intracranial hypertension and mild vision loss, the use of the drug acetazolamide, along with a low-sodium weight-reduction diet, resulted in modest improvement in vision, compared with diet alone.
RARITAN, N.J., April 1, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen), today announced it has submitted a New Drug Application (NDA) to the U.S.
Researchers from UCLA's Jonsson Comprehensive Cancer Center led an international team of scientists in conducting two studies that provide critical insights into two important ways that tumors resist BRAF inhibitors.
- An imitative word; an onomatopoetic word.